As expected, the simultaneous inhibition of ALK and PIM strongly affected cell survival in ALK+ ALCL but not in other PTCL cell lines, synergizing the apoptosis induced by each drug alone only in ALK+ ALCL cells. The gene discussed is ALK; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.